True Wealth Design, LLC Apellis Pharmaceuticals, Inc. Transaction History
True Wealth Design, LLC
- $327 Billion
- Q3 2025
A detailed history of True Wealth Design, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 946 shares of APLS stock, worth $19,610. This represents 0.01% of its overall portfolio holdings.
Number of Shares
946
Previous 567
66.84%
Holding current value
$19,610
Previous $9.82 Million
118.12%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
134MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$253 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$247 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$211 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$202 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$186 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.28B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...